English

Aegerion Pharmaceuticals, Inc.

EDGAR

AEGR Quarterly report (10-Q) · filed 2016-11-04

31 filing records in this dataset, filed from 2010-08-10 to 2016-11-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 32.4 million USD 2016-09-30 Source
Exact value

32363000 USD
Long-term debt including current maturities: 5.8 million USD 2013-06-30 Source
Exact value

5800000 USD
Shares outstanding: 29.5 million shares 2016-09-30 Source
Exact value

29544000 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-11-04.

Financial data available through: 2015-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 2015-12-31
Net income: 9 of 11 periods available· newest 2015-12-31
Operating cash flow: 6 of 11 periods available· newest 2015-12-31
Capital expenditure: 5 of 11 periods available· newest 2015-12-31
Total assets: Multiple units; comparison withheld· newest 2015-12-31
Total liabilities: Multiple units; comparison withheld· newest 2015-12-31
Current assets: Multiple units; comparison withheld· newest 2015-12-31
Current liabilities: Multiple units; comparison withheld· newest 2015-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2015-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2012-12-31
Shares outstanding: Multiple units; comparison withheld· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−Unit1 33.95 million

Prior period

−Unit1 39.39 million

2014-01-01 – 2014-12-31
Current period

−Unit1 73.34 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-73339000 − -39385000 = -33954000 Unit1

-39385000 Unit1 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-73339000 Unit1 · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Year-over-year change in Net income: -33954000 Unit1 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -73339000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1396132 Filing: 000155837016004149 Input fundies:NetIncome: -39385000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1395267 Filing: 000155837016004149
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit1 18.03 million

Prior period

−Unit1 2.05 million

2014-01-01 – 2014-12-31
Current period

Unit1 15.98 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

15981000 − -2051000 = 18032000 Unit1

-2051000 Unit1 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
15981000 Unit1 · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Year-over-year change in Operating cash flow: 18032000 Unit1 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 15981000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394567 Filing: 000155837016004149 Input fundies:OperatingCashFlow: -2051000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394336 Filing: 000155837016004149
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-52.3%

Prior period

Unit1 3.94 million

2014-01-01 – 2014-12-31
Current period

Unit1 1.88 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

1879000 − 3940000 = -2061000 Unit1

3940000 Unit1 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
1879000 Unit1 · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Year-over-year change in Capital expenditure: -2061000 Unit1 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1879000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422231 Filing: 000155837016004149 Input fundies:CapitalExpenditure: 3940000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422041 Filing: 000155837016004149
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−Unit1 6.17 million Exact value Exact value: -6168096 Unit1 2006-01-01 – 2006-12-31: -6168096 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2006-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -6168096 Unit1 Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -6168096 Unit1 (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#414022 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−Unit1 20.19 million Exact value Exact value: -20194242 Unit1 2007-01-01 – 2007-12-31: -20194242 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2007-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -20194242 Unit1 Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -20194242 Unit1 (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#414355 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−Unit1 25.04 million Exact value Exact value: -25035035 Unit1 2008-01-01 – 2008-12-31: -25035035 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2008-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -25035035 Unit1 Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -25035035 Unit1 (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#414690 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−Unit1 12.2 million Exact value Exact value: -12196002 Unit1 2009-01-01 – 2009-12-31: -12196002 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2009-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -12196002 Unit1 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -12196002 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#415025 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	−Unit1 10.53 million Exact value Exact value: -10532259 Unit1 2009-01-01 – 2009-12-31: -10532259 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2009-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: -10532259 Unit1 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -10532259 Unit1 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#412983 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−Unit1 14.25 million Exact value Exact value: -14253841 Unit1 2010-01-01 – 2010-12-31: -14253841 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2010-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -14253841 Unit1 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -14253841 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#415360 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	−Unit1 8.5 million Exact value Exact value: -8499474 Unit1 2010-01-01 – 2010-12-31: -8499474 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2010-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: -8499474 Unit1 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -8499474 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#413174 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unit1 11,724 Exact value Exact value: 11724 Unit1 2010-01-01 – 2010-12-31: 11724 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aegerion Pharmaceuticals, Inc. · 2010-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Capital Expenditure: 11724 Unit1 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 11724 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#437014 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	−Unit1 8.51 million Calculation and evidence -8499474 − 11724 Unit1 Exact free cash flow: -8511198 Unit1 2010-01-01 – 2010-12-31: -8499474 Unit1 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 11724 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aegerion Pharmaceuticals, Inc. · 2010-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Free cash flow: -8511198 Unit1 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8499474 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#413174 Filing: 000119312512117291 Input fundies:CapitalExpenditure: 11724 Unit1 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#437014 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−Unit1 39.47 million Exact value Exact value: -39468187 Unit1 2011-01-01 – 2011-12-31: -39468187 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2011-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -39468187 Unit1 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -39468187 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#415695 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	−Unit1 30.51 million Exact value Exact value: -30507757 Unit1 2011-01-01 – 2011-12-31: -30507757 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2011-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: -30507757 Unit1 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -30507757 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#413364 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	Unit1 631,307 Exact value Exact value: 631307 Unit1 2011-01-01 – 2011-12-31: 631307 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aegerion Pharmaceuticals, Inc. · 2011-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Capital Expenditure: 631307 Unit1 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 631307 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#437201 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.	−Unit1 31.14 million Calculation and evidence -30507757 − 631307 Unit1 Exact free cash flow: -31139064 Unit1 2011-01-01 – 2011-12-31: -30507757 Unit1 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 631307 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aegerion Pharmaceuticals, Inc. · 2011-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Free cash flow: -31139064 Unit1 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30507757 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#413364 Filing: 000119312512117291 Input fundies:CapitalExpenditure: 631307 Unit1 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000119312512117291/aegr-20111231.xml#437201 Filing: 000119312512117291 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−Unit1 63.36 million Exact value Exact value: -63358000 Unit1 2013-01-01 – 2013-12-31: -63358000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2013-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -63358000 Unit1 Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -63358000 Unit1 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394798 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	−Unit1 38.49 million Exact value Exact value: -38487000 Unit1 2013-01-01 – 2013-12-31: -38487000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2013-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: -38487000 Unit1 Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -38487000 Unit1 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394104 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	Unit1 716,000 Exact value Exact value: 716000 Unit1 2013-01-01 – 2013-12-31: 716000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aegerion Pharmaceuticals, Inc. · 2013-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Capital Expenditure: 716000 Unit1 Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 716000 Unit1 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1421852 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	−Unit1 39.2 million Calculation and evidence -38487000 − 716000 Unit1 Exact free cash flow: -39203000 Unit1 2013-01-01 – 2013-12-31: -38487000 Unit1 · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 716000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aegerion Pharmaceuticals, Inc. · 2013-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Free cash flow: -39203000 Unit1 Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38487000 Unit1 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394104 Filing: 000155837016004149 Input fundies:CapitalExpenditure: 716000 Unit1 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1421852 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−Unit1 39.39 million Exact value Exact value: -39385000 Unit1 2014-01-01 – 2014-12-31: -39385000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2014-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -39385000 Unit1 Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -39385000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1395267 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	−Unit1 2.05 million Exact value Exact value: -2051000 Unit1 2014-01-01 – 2014-12-31: -2051000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2014-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: -2051000 Unit1 Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -2051000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394336 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	Unit1 3.94 million Exact value Exact value: 3940000 Unit1 2014-01-01 – 2014-12-31: 3940000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aegerion Pharmaceuticals, Inc. · 2014-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Capital Expenditure: 3940000 Unit1 Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 3940000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422041 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	−Unit1 5.99 million Calculation and evidence -2051000 − 3940000 Unit1 Exact free cash flow: -5991000 Unit1 2014-01-01 – 2014-12-31: -2051000 Unit1 · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 3940000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aegerion Pharmaceuticals, Inc. · 2014-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Free cash flow: -5991000 Unit1 Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2051000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394336 Filing: 000155837016004149 Input fundies:CapitalExpenditure: 3940000 Unit1 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422041 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−Unit1 73.34 million Exact value Exact value: -73339000 Unit1 2015-01-01 – 2015-12-31: -73339000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Net Income: -73339000 Unit1 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -73339000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1396132 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	Unit1 15.98 million Exact value Exact value: 15981000 Unit1 2015-01-01 – 2015-12-31: 15981000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Operating Cash Flow: 15981000 Unit1 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 15981000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394567 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	Unit1 1.88 million Exact value Exact value: 1879000 Unit1 2015-01-01 – 2015-12-31: 1879000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Capital Expenditure: 1879000 Unit1 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 1879000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422231 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.	Unit1 14.1 million Calculation and evidence 15981000 − 1879000 Unit1 Exact free cash flow: 14102000 Unit1 2015-01-01 – 2015-12-31: 15981000 Unit1 · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1879000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aegerion Pharmaceuticals, Inc. · 2015-12-31 Aegerion Pharmaceuticals, Inc. (edgar:1338042) Free cash flow: 14102000 Unit1 Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:45:48Z Snapshot: 4fc1f4b5ed013a04d36a125ffcb20c7ed0d08d2ec4f1370f96661fe89e047715 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338042?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15981000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1394567 Filing: 000155837016004149 Input fundies:CapitalExpenditure: 1879000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/aegr-20151231.xml#1422231 Filing: 000155837016004149 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 2,076 latest values · 2,076 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001338042, 1338042, AEGR, edgar:1338042

Also known as Aegerion Pharmaceuticals Inc, Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc.

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation